missing translation for 'onlineSavingsMsg'
Learn More

NLRX1 Polyclonal Antibody
GREENER_CHOICE

NLRX1 Polyclonal Antibody

Brand:  Invitrogen PA5100025

Product Code. 16636514

  • £448.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

NLRX1 Polyclonal Antibody for Western Blot, ICC/IF, IHC (P)

TRUSTED_SUSTAINABILITY
Specifications

Specifications

NLRX1
Polyclonal
Unconjugated
NLRX1
BC034204; Caterpiller protein 11.3; CLR11.3; DLNB26; FLJ21478; MGC131937; MGC21025; NLR family member X1; NLRX1; NOD26; NOD5; NOD9; NOD-like receptor X1; nucleotide-binding domain and leucine-rich repeat containing; nucleotide-binding oligomerization domain protein 26; Nucleotide-binding oligomerization domain protein 5; nucleotide-binding oligomerization domain protein 9; nucleotide-binding oligomerization domain, leucine rich repeat containing X1; OTTHUMP00000205768; OTTHUMP00000205769; RGD1311293
Rabbit
Affinity Chromatography
RUO
270151, 315599, 79671
-20°C
Liquid
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Q3TL44, Q5FVQ8, Q86UT6
NLRX1
A synthesized peptide derived from human NLRX1(Accession Q86UT6), corresponding to amino acid residues R291-S341.
100 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.